MetLife Investment Management, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1529735
Whippany, NJ
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,356,700
+$117,473 QoQ
Shares Held
135,670
+4.2% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#109
of 318 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. BCRX ranks #15 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
512,924 | $26,877,217 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
20,421 | $11,064,710 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
51,732 | $8,718,911 | |
| 4 | ZTS |
Zoetis Inc.
|
108,947 | $7,828,931 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
224,462 | $7,782,097 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
68,281 | $7,575,094 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
240,384 | $5,915,850 | |
| 8 | VTRS |
Viatris Inc
|
266,382 | $4,230,146 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,356,700 | 135,670 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,239,227 | 130,171 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $919,253 | 117,853 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $895,278 | 117,955 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,113,521 | 124,277 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $914,385 | 121,918 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $954,656 | 126,949 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $910,100 | 119,750 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $740,055 | 119,750 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $451,967 | 88,970 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $583,192 | 97,361 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $689,315 | 97,361 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $685,421 | 97,361 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $811,990 | 97,361 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $1,117,704 | 97,361 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $1,226,748 | 97,361 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $1,030,079 | 97,361 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $1,583,089 | 97,361 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $858,893 | 62,014 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $891,141 | 62,014 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $1,077,925 | 68,180 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $693,390 | 68,180 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $542,732 | 72,850 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $241,078 | 70,081 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $333,585 | 70,081 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $78,178 | 39,089 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||